Search research articles
Contact Us
Filters
Showing results (101-110 of 176) with videos related to
Page
of 18
Sort By:
Therapeutic Advances in Infectious Disease
|
July 18, 2022
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections
Laura C Fanucchi, Sean M Murphy, Hilary Surratt, et al.
Journal of the American Veterinary Medical Association
|
July 31, 2018
Intra-abdominal complications following intestinal anastomoses by suture and staple techniques in dogs
Christine M DePompeo, Laura Bond, Yelena E George, et al.
Research Square
|
June 9, 2023
Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
Shayla Nolen, Andrew J Trinidad, Ashly E Jordan, et al.
Harm Reduction Journal
|
October 18, 2023
Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
Shayla Nolen, Andrew J Trinidad, Ashly E Jordan, et al.
Addiction Science & Clinical Practice
|
November 10, 2024
Protocol for a randomized controlled trial with a stepped care approach, utilizing PrEP navigation with and without contingency management, for transgender women and sexual minority men with a substance use disorder: Assistance Services Knowledge-PrEP (A.S.K.-PrEP)
Cathy J Reback, Raphael J Landovitz, David Benkeser, et al.
Journal of Telemedicine and Telecare
|
August 4, 2023
Telemedicine-delivered treatment for substance use disorder: A scoping review
Huyen Pham, Chunqing Lin, Yuhui Zhu, et al.
Annals of Internal Medicine
|
December 18, 2018
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
Sean M Murphy, Kathryn E McCollister, Jared A Leff, et al.
Contemporary Clinical Trials
|
April 1, 2021
A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study
E Jennifer Edelman, James Dziura, Yanhong Deng, et al.
JAMA Network Open
|
April 14, 2023
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, et al.
Journal of Substance Abuse Treatment
|
September 22, 2019
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City
Czarina N Behrends, Denise Paone, Michelle L Nolan, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 176) with videos related to
Sort By:
Page
of 18
Therapeutic Advances in Infectious Disease
|
July 18, 2022
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections
Laura C Fanucchi, Sean M Murphy, Hilary Surratt, et al.
Journal of the American Veterinary Medical Association
|
July 31, 2018
Intra-abdominal complications following intestinal anastomoses by suture and staple techniques in dogs
Christine M DePompeo, Laura Bond, Yelena E George, et al.
Research Square
|
June 9, 2023
Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
Shayla Nolen, Andrew J Trinidad, Ashly E Jordan, et al.
Harm Reduction Journal
|
October 18, 2023
Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
Shayla Nolen, Andrew J Trinidad, Ashly E Jordan, et al.
Addiction Science & Clinical Practice
|
November 10, 2024
Protocol for a randomized controlled trial with a stepped care approach, utilizing PrEP navigation with and without contingency management, for transgender women and sexual minority men with a substance use disorder: Assistance Services Knowledge-PrEP (A.S.K.-PrEP)
Cathy J Reback, Raphael J Landovitz, David Benkeser, et al.
Journal of Telemedicine and Telecare
|
August 4, 2023
Telemedicine-delivered treatment for substance use disorder: A scoping review
Huyen Pham, Chunqing Lin, Yuhui Zhu, et al.
Annals of Internal Medicine
|
December 18, 2018
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
Sean M Murphy, Kathryn E McCollister, Jared A Leff, et al.
Contemporary Clinical Trials
|
April 1, 2021
A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study
E Jennifer Edelman, James Dziura, Yanhong Deng, et al.
JAMA Network Open
|
April 14, 2023
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, et al.
Journal of Substance Abuse Treatment
|
September 22, 2019
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City
Czarina N Behrends, Denise Paone, Michelle L Nolan, et al.
Page
of 18